Furthermore, immunoblotting assay also showed that the protein levels of MELK, phospho-FOXM1 (T600), and its downstream targets (PLK1, Cyclin B1 and Aurora B) were much higher in tumor cell lysates derived from MELK-overexpressing mice than those from the control group (Figure 5D). This evidence concerns the gene PLK1 and neoplasm.